Alfred E. Smith IV Appointed to Provectus Pharmaceuticals's Board of Directors - MarketWatch (press release)

Alfred E. Ian Smith IV Appointed to Provectus Pharmaceuticals's Board of Directors MarketWatch (press release) Its dermatological drug PH-10 too targets abnormal or pathologic cells, with the actual focus on psoriasis and atopic dermatitis. Provectus has recently completed its state of matter 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a ... and more » Link To Article